Radiation and immunotherapy: Renewed allies in the war on cancer

por Seung, Steven K., Curti, Brendan, Crittenden, Marka, Urba, Walter
Publicado 2012

Comparison of proteomic and genomic analyses of vaccine cell lines shows men receiving prostate gvax immunotherapy develop increased humoral responses to common cell line proteins...

por Hulett, Tyler, Puri, Sachin, Curti, Brendan, Urba, Walter J, Fox, Bernard A
Publicado 2014

GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs

por Guerrouahen, Bella S., Hahn, Tobias, Alderman, Zefora, Curti, Brendan, Urba, Walter, Akporiaye, Emmanuel T.
Publicado 2016

Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis

por Kovacsovics-Bankowski, Magdalena, Chisholm, Lana, Vercellini, Jonna, Crittenden, Marka, Lary, Scot, Curti, Brendan, Weinberg, Andrew
Publicado 2013

Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer

por Curti, Brendan D, Akporiaye, Emmanuel, Sutcliffe, Kim, Bahjat, Keith S, Koguchi, Yoshinobu, Cramer, Julie, Urba, Walter
Publicado 2015

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies

por Fox, Bernard A., Urba, Walter J., Jensen, Shawn M., Page, David B., Curti, Brendan D., Sanborn, Rachel E., Leidner, Rom S.
Publicado 2023

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment

por Andtbacka, Robert HI, Curti, Brendan D, Hallmeyer, Sigrun, Feng, Zipei, Paustian, Christopher, Bifulco, Carlo, Fox, Bernard, Grose, Mark, Shafren, Darren
Publicado 2015

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

por Payne, Roxanne, Glenn, Lyn, Hoen, Helena, Richards, Beverley, Smith, John W, Lufkin, Robert, Crocenzi, Todd S, Urba, Walter J, Curti, Brendan D
Publicado 2014

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance

por Couey, Marcus A., Bell, R. Bryan, Patel, Ashish A., Romba, Meghan C., Crittenden, Marka R., Curti, Brendan D., Urba, Walter J., Leidner, Rom S.
Publicado 2019

Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

por Koguchi, Yoshinobu, Iwamoto, Noriko, Shimada, Takashi, Chang, Shu-Ching, Cha, John, Curti, Brendan D, Urba, Walter J, Piening, Brian D, Redmond, William L
Publicado 2021

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers

por Mougdil, Tarsem, Paustian, Christopher, Feng, Zipei, Leidner, Rom, Dubay, Christopher, Curti, Brendan D, Hu, Hong-Ming, Urba, Walter, Bifulco, Carlo, Fox, Bernard, Bell, Brian
Publicado 2015

Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer

por Puri, Sachin, Han, Jing, Joshi, Bharat H, Healy, Daniel, Siebert, Janet, Paustian, Christopher, Dubay, Christopher, Bahjat, Keith S, Curti, Brendan, Urba, Walter J, Fox, Bernard A
Publicado 2014

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma

por Feng, Zipei, Puri, Sachin, Moudgil, Tarsem, Wood, William, Hoyt, Clifford C., Wang, Chichung, Urba, Walter J., Curti, Brendan D., Bifulco, Carlo B., Fox, Bernard A.
Publicado 2015

Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy

por Friedman, David J, Young, Kristina, Baird, Jason R, Cottam, Benjamin, Savage, Talicia, Newell, Pippa, Kasiewicz, Melissa, Redmond, William, Curti, Brendan, Crocenzi, Todd, Gough, Michael J, Crittenden, Marka
Publicado 2014

Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy

por Sckisel, Gail D., Mirsoian, Annie, Minnar, Christine M., Crittenden, Marka, Curti, Brendan, Chen, Jane Q., Blazar, Bruce R., Borowsky, Alexander D., Monjazeb, Arta M., Murphy, William J.
Publicado 2017

Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

por Curti, Brendan, Crittenden, Marka, Seung, Steven K, Fountain, Christopher B, Payne, Roxanne, Chang, ShuChing, Fleser, Jessica, Phillips, Kimberly, Malkasian, Ian, Dobrunick, Lyn B, Urba, Walter J
Publicado 2020

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab

por Koguchi, Yoshinobu, Hoen, Helena, Bambina, Shelly, Rynning, Michael, Fuerstenberg, Richard, Feng, Zipei, Fox, Bernard, Bifulco, Carlo, Curti, Brendan D, Urba, Walter, Milburn, Christina, Korman, Alan J, Bahjat, Keith S
Publicado 2015

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

por Bigelow, Emma, Saria, Suchi, Piening, Brian, Curti, Brendan, Dowdell, Alexa, Weerasinghe, Roshanthi, Bifulco, Carlo, Urba, Walter, Finkelstein, Noam, Fertig, Elana J, Baras, Alex, Zaidi, Neeha, Jaffee, Elizabeth, Yarchoan, Mark
Publicado 2022

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies

por Moudgil, Tarsem, Bell, R Bryan, Leidner, Rom, Feng, Zipei, Paustian, Christopher, Dubay, Christopher, Hilton, Traci L, Curti, Brendan, Urba, Walter J, Bifulco, Carlo B, Hu, Hong-Ming, Fox, Bernard A
Publicado 2014

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

por van de Ven, Rieneke, Hilton, Traci L., Hu, Hong-Ming, Dubay, Christopher J., Haley, Daniel, Paustian, Christopher, Puri, Sachin, Urba, Walter J., Curti, Brendan D., Aung, Sandra, Fox, Bernard A.
Publicado 2018